JPWO2021177387A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021177387A5
JPWO2021177387A5 JP2022504446A JP2022504446A JPWO2021177387A5 JP WO2021177387 A5 JPWO2021177387 A5 JP WO2021177387A5 JP 2022504446 A JP2022504446 A JP 2022504446A JP 2022504446 A JP2022504446 A JP 2022504446A JP WO2021177387 A5 JPWO2021177387 A5 JP WO2021177387A5
Authority
JP
Japan
Prior art keywords
fibroblasts
pharmaceutical composition
epo
kidney
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022504446A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021177387A1 (https=
JP7229618B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/008325 external-priority patent/WO2021177387A1/ja
Publication of JPWO2021177387A1 publication Critical patent/JPWO2021177387A1/ja
Publication of JPWO2021177387A5 publication Critical patent/JPWO2021177387A5/ja
Priority to JP2023017770A priority Critical patent/JP2023053044A/ja
Application granted granted Critical
Publication of JP7229618B2 publication Critical patent/JP7229618B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022504446A 2020-03-04 2021-03-04 エリスロポエチン産生能が亢進された線維芽細胞 Active JP7229618B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023017770A JP2023053044A (ja) 2020-03-04 2023-02-08 エリスロポエチン産生能が亢進された線維芽細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020036421 2020-03-04
JP2020036421 2020-03-04
PCT/JP2021/008325 WO2021177387A1 (ja) 2020-03-04 2021-03-04 エリスロポエチン産生能が亢進された線維芽細胞

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023017770A Division JP2023053044A (ja) 2020-03-04 2023-02-08 エリスロポエチン産生能が亢進された線維芽細胞

Publications (3)

Publication Number Publication Date
JPWO2021177387A1 JPWO2021177387A1 (https=) 2021-09-10
JPWO2021177387A5 true JPWO2021177387A5 (https=) 2022-12-01
JP7229618B2 JP7229618B2 (ja) 2023-02-28

Family

ID=77614075

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022504446A Active JP7229618B2 (ja) 2020-03-04 2021-03-04 エリスロポエチン産生能が亢進された線維芽細胞
JP2023017770A Pending JP2023053044A (ja) 2020-03-04 2023-02-08 エリスロポエチン産生能が亢進された線維芽細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023017770A Pending JP2023053044A (ja) 2020-03-04 2023-02-08 エリスロポエチン産生能が亢進された線維芽細胞

Country Status (9)

Country Link
US (1) US20220411761A1 (https=)
EP (1) EP4116412A4 (https=)
JP (2) JP7229618B2 (https=)
KR (1) KR20220148184A (https=)
CN (1) CN115210361B (https=)
AU (1) AU2021230209B2 (https=)
CA (1) CA3174551A1 (https=)
IL (1) IL296125A (https=)
WO (1) WO2021177387A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2023037868A1 (https=) * 2021-09-08 2023-03-16
WO2025135526A1 (ko) * 2023-12-19 2025-06-26 재단법인대구경북과학기술원 피부 또는 모발의 멜라닌 색소 조절용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101031B (pt) * 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
US6946246B1 (en) * 1997-04-08 2005-09-20 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Production of functional proteins: balance of shear stress and gravity
JP2004516820A (ja) 2000-08-25 2004-06-10 キュラジェン コーポレイション 新規タンパク質およびそれらのタンパク質をコードする核酸
JP5404951B2 (ja) 2008-04-22 2014-02-05 キヤノン株式会社 制御装置
KR101735125B1 (ko) 2008-11-12 2017-05-15 리젠메드 (케이만) 엘티디. 분리된 신장 세포 및 이의 용도
CN103154236B (zh) 2010-05-12 2016-08-31 再生医学Tx有限责任公司 生物活性肾细胞
CA2954743C (en) 2014-07-11 2022-03-15 Metcela Inc. Cardiac cell culture material
KR102407387B1 (ko) 2017-02-24 2022-06-10 가부시키가이샤 메토세라 섬유아세포를 포함하고, 심장 질환들의 치료를 위하여 사용될 수 있는 주사용 조성물, 및 치료 용도를 위하여 섬유아세포를 생산하는 방법
CA3110831A1 (en) * 2018-08-29 2020-03-05 Metcela Inc. Method for producing fibroblast, and g-csf-positive fibroblast mass

Similar Documents

Publication Publication Date Title
JPWO2021177387A5 (https=)
Trigilia Small-firm development and political subcultures in Italy
Bryan et al. The emerging role of cellular post-translational modifications in modulating growth and productivity of recombinant Chinese hamster ovary cells
Da-Silva et al. Improving prediction of metabolic clearance using quantitative extrapolation of results obtained from human hepatic micropatterned cocultures model and by considering the impact of albumin binding
CN102876626A (zh) 支持cho高密度悬浮生长的无血清无蛋白全化学成分界定的培养基
CN201702366U (zh) 组合模具
JP2021118728A5 (https=)
CN202880764U (zh) 一种新型机械设备升降平台
Chen et al. Quorum sensing regulating the productivity and stability of cross-feeding cocultivation
Wang et al. Saving and growth effects of demographic transition: the population factor in the sustainability of China’s economic growth
CN205246680U (zh) 一种用于肿瘤干细胞捕获和释放的微流控芯片
CN1686121A (zh) 苯磺酸氨氯地平分散片及其制备方法
Arora Healthcare biotechnology firms in India: Evolution, structure and growth
CN205362389U (zh) 大型逆向斜楔机构
CN209006594U (zh) 一种轮毂座圈二合一模具
CN101278920B (zh) 丹酚酸微孔渗透泵控释片及其制备方法
CN206091042U (zh) 高强度铝板
WU et al. Construction of ecological zoning of plateau lake basin based on spatial conflict and eco-environmental quality: A case of Dianchi Lake Basin
CN201906612U (zh) 可拆式微量滴定板结构
CN202011129U (zh) 可转角度的弹定模斜抽芯机构
Gordiichuk et al. Development of a Human 3D Immune‐Competent Neurovascular Model Enabling Time‐Resolved Monitoring of Neuroinflammatory Dynamics and Neuroimmune Interactions
Chen et al. Traditional Chinese Medicine, and Health and Wellness Industry: Analysis and Discussion on the Integrated Development under the Background of Big Health
CN206863368U (zh) 错槽式眼镜框用金属线材
CN111745051A (zh) 一种转椅长脚管折边模
CN223226083U (zh) 一种新型可用于毒理学研究的3d细胞培养的培养模具